The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase II/III trial comparing hepatectomy followed by mFOLFOX6 with hepatectomy alone for liver metastasis from colorectal cancer: JCOG0603 study.
 
Yukihide Kanemitsu
Honoraria - Chugai Pharma; Covidien; Ethicon; Intuitive Surgical
Consulting or Advisory Role - Covidien
 
Yasuhiro Shimizu
No Relationships to Disclose
 
Junki Mizusawa
Honoraria - Chugai Pharma; Taiho Pharmaceutical
 
Yoshitaka Inaba
No Relationships to Disclose
 
Tetsuya Hamaguchi
Honoraria - Bayer; Bristol-Myers Squibb Japan; Chugai Pharma; Fujifilm; Lilly; Merck Serono; Novartis; Ono Pharmaceutical; Sanofi; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical
Research Funding - Chugai Pharma (Inst); Eisai (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Dai Shida
No Relationships to Disclose
 
Masayuki Ohue
No Relationships to Disclose
 
Koji Komori
No Relationships to Disclose
 
Akio Shiomi
No Relationships to Disclose
 
Manabu Shiozawa
No Relationships to Disclose
 
Jun Watanabe
No Relationships to Disclose
 
Takeshi Suto
No Relationships to Disclose
 
Yusuke Kinugasa
No Relationships to Disclose
 
Yasumasa Takii
No Relationships to Disclose
 
Hiroyuki Bando
No Relationships to Disclose
 
Takaya Kobatake
No Relationships to Disclose
 
Tomoyuki Kato
No Relationships to Disclose
 
Yasuhiro Shimada
Honoraria - Chugai Pharma; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Lilly Japan (Inst); MSD K.K (Inst); Taiho Pharmaceutical (Inst)
 
Hiroshi Katayama
No Relationships to Disclose
 
Haruhiko Fukuda
Honoraria - Chugai Pharma; Taiho Pharmaceutical